Last reviewed · How we verify
VERVE-101
At a glance
| Generic name | VERVE-101 |
|---|---|
| Sponsor | Verve Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VERVE-101 CI brief — competitive landscape report
- VERVE-101 updates RSS · CI watch RSS
- Verve Therapeutics, Inc. portfolio CI